Machine learning for prediction of sudden cardiac death in heart failure patients with low left ventricular ejection fraction: study protocol for a retroprospective multicentre registry in China.

Journal: BMJ open
Published Date:

Abstract

INTRODUCTION: Left ventricular ejection fraction (LVEF) ≤35%, as current significant implantable cardioverter-defibrillator (ICD) indication for primary prevention of sudden cardiac death (SCD) in heart failure (HF) patients, has been widely recognised to be inefficient. Improvement of patient selection for low LVEF (≤35%) is needed to optimise deployment of ICD. Most of the existing prediction models are not appropriate to identify ICD candidates at high risk of SCD in HF patients with low LVEF. Compared with traditional statistical analysis, machine learning (ML) can employ computer algorithms to identify patterns in large datasets, analyse rules automatically and build both linear and non-linear models in order to make data-driven predictions. This study is aimed to develop and validate new models using ML to improve the prediction of SCD in HF patients with low LVEF.

Authors

  • Fanqi Meng
    Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Zhihua Zhang
    Department of Plastic and Cosmetic Surgery, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120 Guangdong, P.R. China.
  • Xiaofeng Hou
    Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Zhiyong Qian
    Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Yao Wang
    Department of Gastrointestinal Surgery, Zhongshan People's Hospital, Zhongshan, Guangdong, China.
  • Yanhong Chen
    Department of Cardiology, Wuhan Asia Heart Hospital, Wuhan, Hubei, China.
  • Yilian Wang
    Department of Cardiology, The Second People's Hospital of Lianyungang, Lianyungang, Jiangsu, China.
  • Ye Zhou
    Department of Cardiology, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.
  • Zhen Chen
    School of Basic Medicine, Qingdao University, Qingdao 266021, China.
  • Xiwen Zhang
    Department of Cardiology, The First People's Hospital of Huaian, Huaian, Jiangsu, China.
  • Jing Yang
    Beijing Novartis Pharma Co. Ltd., Beijing, China.
  • Jinlong Zhang
    Tianjin Institute of Animal Sciences, Tianjin, China.
  • Jianghong Guo
    Department of Cardiology, Rugao People's Hospital, Rugao, Jiangsu, China.
  • Kebei Li
    Department of Cardiology, The First People's Hospital of Zhangjiagang, Zhangjiagang, Jiangsu, China.
  • Lu Chen
    Ultrasonic Department, Zhongda Hospital Affiliated to Southeast University, Nanjing, 210009, China.
  • Ruijuan Zhuang
    Department of Cardiology, The Third People's Hospital of Wuxi, Wuxi, Jiangsu, China.
  • Hai Jiang
    Department of Obstetrics and Gynecology, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
  • Weihua Zhou
    School of Computing, University of Southern Mississippi, Hattiesburg, MS, United States of America.
  • Shaowen Tang
    Department of Epidemiology, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Yongyue Wei
    Department of Biostatistics, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Jiangang Zou
    Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.